LNG/EE Use Safe on Endometrial Histology

JUNE 01, 2006
Susan Farley

Levonorgestrel (LNG) 90 μg/ethinyl estradiol (EE) 20 μg was shown to have a good endometrial safety profile after a substudy of a phase 3, open-label, 1- year trial that was conducted at 92 sites in the United States and Canada. Healthy, sexually active women, aged 18 to 49 years, took 1 pill of LNG 90 μg/EE 20 μg daily for 12 months. The 93 participants in the histology portion of the study had an endometrial biopsy at the pretreatment visit and during the last month. The results of the biopsies showed no inconsistent changes in the endometria, and there were no findings of hyperplasia or malignancy.

Ms. Farley is a freelance medical writer based in Wakefield, RI.




SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

Pharmacy Times Strategic Alliance
 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.